Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P30044 (
antioxidant enzyme
)
8,037
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Oxidative stress is known to participate in the pathogenesis of HCV infection. The aim of this study was to investigate the relationship between antioxidant defence state, malondialdehyde (MDA) and viral load in patients with
hepatitis C
virus (HCV) infection. Fifty patients who were positive for serological and molecular markers of HCV infection, and 40 healthy volunteers as control group were included in the study. The patients were classified according to their viral loads, and the catalase, superoxide dismutase (SOD) and glutathione peroxidase (GP) activities of erythrocytes and MDA in sera of all groups were measured. These substances were detected by using the methods described by Aebi, Woolliams et al, Paglia and Valentine, Draper and Hadley, respectively. As a result, decrease in SOD and GP levels and increase in MDA and catalase levels have been detected in HCV infected patients when compared with healthy controls, and these differences were statistically significant (p<0.05, t=19.3),except for catalase. However, there were no statistically significant difference among groups classified according to viral load (p>0.05, t=1.6). Although our data in HCV infected patients demonstrate a significant decrease in
antioxidant enzyme
levels and a significant increase in MDA levels, a marker of oxidative stress, it could not possible to make a correlation between these differences and the viral loads of patients.
...
PMID:[The relationship between viral load and malondialdehyde and antioxidant enzymes in patients with hepatitis C virus infection]. 1677 57
Hepatitis C
virus (HCV) replication is associated with the endoplasmic reticulum, where the virus can induce cellular stress. Oxidative cell damage plays an important role in HCV physiopathology. Oxidative stress is triggered when the concentration of oxygen species in the extracellular or intracellular environment exceeds antioxidant defenses. Cells are protected and modulate oxidative stress through the interplay of intracellular antioxidant agents, mainly glutathione system (GSH) and thioredoxin; and
antioxidant enzyme
systems such as superoxide dismutase, catalase, GSH peroxidase, and heme oxygenase-1. Also, the use of natural and synthetic antioxidants (vitamin C and E, N-acetylcysteine, glycyrrhizin, polyenylphosphatidyl choline, mitoquinone, quercetin, S-adenosylmethionine and silymarin) has already shown promising results as co-adjuvants in HCV therapy. Despite all the available information, it is not known how different agents with antiviral activity can interfere with the modulation of the cell redox state induced by HCV and decrease viral replication. This review describes an evidence-based consensus on molecular mechanisms involved in HCV replication and their relationship with cell damage induced by oxidative stress generated by the virus itself and cell antiviral machinery. It also describes some molecules that modify the levels of oxidative stress in HCV-infected cells.
...
PMID:Oxidative stress modulation in hepatitis C virus infected cells. 2669 73